Zhitong Finance App News, Lu Kang Pharmaceutical (600789.SH) issued an announcement. Recently, Shandong Lukang Pharmaceutical Group Saite Co., Ltd. (“Sete”), the holding subsidiary of the company, received the “Drug Registration Certificate” (approval number: 2025S03900, 2025S03901) for finasteride tablets issued by the State Drug Administration. The drug is a generic drug approved in 4 categories according to the new registration classification, and is considered to have passed the consistent evaluation of the quality and efficacy of generic drugs.

Zhitong Finance App News, Lu Kang Pharmaceutical (600789.SH) issued an announcement. Recently, Shandong Lukang Pharmaceutical Group Saite Co., Ltd. (“Sete”), the holding subsidiary of the company, received the “Drug Registration Certificate” (approval number: 2025S03900, 2025S03901) for finasteride tablets issued by the State Drug Administration. The drug is a generic drug approved in 4 categories according to the new registration classification, and is considered to have passed the consistent evaluation of the quality and efficacy of generic drugs.